Form 8-K - Current report:
SEC Accession No. 0001104659-25-011211
Filing Date
2025-02-11
Accepted
2025-02-11 08:41:02
Documents
17
Period of Report
2025-02-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm256024d9_8k.htm   iXBRL 8-K 44238
2 EXHIBIT 3.1 tm256024d9_ex3-1.htm EX-3.1 7036
3 EXHIBIT 3.2 tm256024d9_ex3-2.htm EX-3.2 103534
4 EXHIBIT 99.1 tm256024d9_ex99-1.htm EX-99.1 9345
8 GRAPHIC tm256024d9_ex99-1img001.jpg GRAPHIC 2644
  Complete submission text file 0001104659-25-011211.txt   380713

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrns-20250207.xsd EX-101.SCH 3030
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20250207_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20250207_pre.xml EX-101.PRE 22369
19 EXTRACTED XBRL INSTANCE DOCUMENT tm256024d9_8k_htm.xml XML 3958
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 25607796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)